Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide (Q33336619)

25 July 2017

title

Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide (English)

1 reference

25 July 2017

1 reference

1 reference

1 reference

Chamberlain MC

1

1 reference

25 July 2017

publication date

1 February 2001

1 reference

25 July 2017

1 reference

25 July 2017

volume

24

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

117-121

1 reference

Supratentorial ependymomas in adult patients

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Intracranial ependymoma in children: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Clinical and neuroradiologic findings in infants with intracranial ependymomas. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Infratentorial ependymomas in childhood: prognostic factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Deferring adjuvant therapy for totally resected intracranial ependymoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Intracranial ependymomas: results of treatment with partial or whole brain irradiation without spinal irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Intracranial ependymoma long term outcome, patterns of failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Supratentorial ependymomas. Neuroimaging and clinicopathological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Lack of histopathological correlation of malignant ependymomas with postoperative survival

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Intracranial ependymomas of childhood: long-term outcome and prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Prognostic factors in infants and very young children with intracranial ependymomas

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Disseminated ependymomas of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Extraneural metastases in ependymoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

The clinical pharmacology of etoposide and teniposide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

The clinical pharmacology of etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

The clinical pharmacology of VM26 and VP16-213. A brief overview

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Future directions for etoposide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Chronic oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Recurrent brainstem gliomas treated with oral VP-16.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Chronic oral VP-16 for recurrent medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Recurrent cerebellar gliomas: salvage therapy with oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Response of recurrent medulloblastoma to low-dose oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

Toward the development of a play performance scale for children (PPSC).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2800%2900249-6

7 January 2021

10.1016/S0887-8994(00)00249-6

Identifiers

DOI

1 reference

25 July 2017

1 reference